表紙
市場調查報告書

心臟再同步化治療市場:各產品類型(心臟去顫器、心律調節器)、各終端用戶(醫院、心臟中心、門診外科中心):至2024年的預測

Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 829740
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
Back to Top
心臟再同步化治療市場:各產品類型(心臟去顫器、心律調節器)、各終端用戶(醫院、心臟中心、門診外科中心):至2024年的預測 Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024
出版日期: 2019年04月29日內容資訊: 英文 108 Pages
簡介

全球心臟再同步化治療市場,預測將從2019年的41億美元到2024年末達51億美元的規模,年複合成長率預計將為4.4%。高齡化伴隨的標的疾病的發病率上升,技術進步的投資和支援的擴大等推動市場成長。

本報告提供全球心臟再同步化治療市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 各類型市場

  • 簡介
  • 心臟去顫器
  • 心律調節器

第7章 各終端用戶市場

  • 簡介
  • 醫院、心臟中心
  • 門診外科中心

第8章 各地區市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 競爭趨勢

  • 概要
  • 市場佔有率分析
  • 競爭模式

第10章 企業簡介

第11章 附錄

圖表

目錄
Product Code: MD 7035

"The CRT market is projected to grow at a CAGR of 4.4% during the forecast period (2019-2024)."

The CRT market is projected to reach USD 5.1 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 4.4%. The growth of the CRT market is mainly driven by the increasing incidence of target disease and growth in the geriatric population. Rising investments and support, along with technological advancements, are also contributing to the growth of the market. However, unfavorable healthcare reforms in the US are expected to limit market growth to a certain extent.

"By product type, the cardiac resynchronization therapy defibrillators (CRT-D) segment accounted for the largest share of the market in 2018."

On the basis of product type, the CRT market is segmented into cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

"By end user, the hospitals & cardiac centers segment is expected to dominate the CRT market during the forecast period."

On the basis of end user, the CRT market is segmented into the hospitals & cardiac centers and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.

"APAC is expected to witness the highest growth during the forecast period."

The Asia Pacific region is projected to register the highest growth rate in the CRT systems market during the forecast period. Favorable reimbursement scenario in Japan, the rising geriatric population in China, rising incidence of CVDs, improving healthcare infrastructure, growing middle-class population, and rising disposable income levels in India are some of the key factors driving the growth of the CRT systems market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-55%, Tier 2-25%, and Tier 3-20%
  • By Designation: C-level-43%, Director-level-32%, and Others-25%
  • By Region: North America-38%, Europe-23%, Asia Pacific-29%, Rest of World-10%

The prominent players in the CRT market are: Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

Research Coverage:

The report analyzes the market for various cardiac resynchronization therapy (CRT) systems and their adoption pattern. It aims at estimating the market size and future growth potential of the CRT market and the different segments. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the CRT market
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the CRT market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global CRT market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the CRT market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • 4.3 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • 4.4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of target diseases
      • 5.2.1.2 Growth in the geriatric population
      • 5.2.1.3 Growing investments, funds, and grants
      • 5.2.1.4 Technological advancements
      • 5.2.1.5 MRI-safe device technology
      • 5.2.1.6 Wireless CRT
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable healthcare reforms in the US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled cardiac surgeons
      • 5.2.4.2 Product recalls
      • 5.2.4.3 Battery life and device replacement cost

6 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS
    • 6.2.1 CRT - DEFIBRILLATORS ACCOUNTED FOR THE LARGEST SHARE OF THE CRT SYSTEMS MARKET IN 2018
  • 6.3 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS
    • 6.3.1 THE CRT - PACEMAKERS MARKET WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CARDIAC CENTERS
    • 7.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET
  • 7.3 AMBULATORY SURGERY CENTERS
    • 7.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE THE ADOPTION OF CRT DEVICES

8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 Technological advancements-A key factor driving market growth
    • 8.2.2 CANADA
      • 8.2.2.1 Growing focus of government and private organizations on providing research funding is expected to drive the market in Canada
  • 8.3 EUROPE
    • 8.3.1 GERMANY
      • 8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth
    • 8.3.2 UK
      • 8.3.2.1 Increasing geriatric population and increasing use of CRT devices to drive market growth
    • 8.3.3 FRANCE
      • 8.3.3.1 Growing use of cardiac resynchronization therapy devices for heart failure to support market growth
    • 8.3.4 ITALY
      • 8.3.4.1 Increasing incidence of CVDs to drive the adoption of cardiac resynchronization therapy devices in the country
    • 8.3.5 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 JAPAN
      • 8.4.1.1 Favourable reimbursement policy to support market growth
    • 8.4.2 CHINA
      • 8.4.2.1 Growing geriatric population to drive the market for cardiac resynchronization therapy systems
    • 8.4.3 INDIA
      • 8.4.3.1 Growing middle-class population & rising disposable income levels are supporting the growth of the CRT systems market in India
    • 8.4.4 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 MARKET SHARE ANALYSIS
    • 9.2.1 MEDTRONIC
    • 9.2.2 ABBOTT LABORATORIES
    • 9.2.3 BOSTON SCIENTIFIC CORPORATION
  • 9.3 COMPETITIVE SCENARIO
    • 9.3.1 PRODUCT LAUNCHES AND APPROVALS
    • 9.3.2 EXPANSIONS
    • 9.3.3 ACQUISITIONS, 2017 - 2018

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)*

  • 10.1 MEDTRONIC, PLC.
  • 10.2 ABBOTT LABORATORIES
  • 10.3 BOSTON SCIENTIFIC CORPORATION
  • 10.4 BIOTRONIK
  • 10.5 MEDICO S.P.A.
  • 10.6 MICROPORT SCIENTIFIC CORPORATION
  • Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: POPULATION STATISTICS, 2015 VS 2030 VS 2050 (MILLION INDIVIDUALS)
  • TABLE 2: LIST OF PRODUCT RECALLS
  • TABLE 3: BATTERY SURVIVAL RATE BY DEVICE MANUFACTURER
  • TABLE 4: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 7: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 9: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 10: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017-2024 (UNITS)
  • TABLE 14: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 16: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 19: CLINICAL TRIALS RELATED TO CARDIAC RESYNCHRONIZATION THERAPY DEVICES
  • TABLE 20: US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 22: CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 23: CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 24: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 26: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 29: GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 30: GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 31: RESEARCH STUDIES RELATED TO CRT DEVICES IN THE UK
  • TABLE 32: UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 34: FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 35: FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 36: ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 39: ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 41: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 43: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 47: JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 48: CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 53: ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
  • TABLE 56: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 58: PRODUCT LAUNCHES AND APPROVALS, 2017 - 2018
  • TABLE 59: EXPANSIONS, 2016

LIST OF FIGURES

  • FIGURE 1: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SEGMENTATION
  • FIGURE 2: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
  • FIGURE 9: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHIC SNAPSHOT: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, 2018
  • FIGURE 11: INCREASING INCIDENCE TARGET DISEASE TO DRIVE THE GROWTH OF THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET
  • FIGURE 12: DEFIBRILLATORS TO DOMINATE THE NORTH AMERICAN MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: CRT - DEFIBRILLATORS TO DOMINATE THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 16: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 17: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 18: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2019 VS. 2024
  • FIGURE 19: NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 20: EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 22: ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
  • FIGURE 23: MARKET SHARE ANALYSIS BY KEY PLAYERS (2015-2018)
  • FIGURE 24: MEDTRONIC, PLC: COMPANY SNAPSHOT (2017)
  • FIGURE 25: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 26: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 27: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2017)
Back to Top